104. Psychedelics in New Zealand with Dr Suresh Muthukumaraswamy
About this episode
In this episode, we meet with Dr. Suresh Muthukumaraswamy, an Associate Professor of Pharmacy in Auckland. Dr. Muthukumaraswamy discusses his early research, exploring the functional connectivity of substances like DMT and Ketamine. He proceeds to share insights into his breakthrough realisation regarding the disparity between the self-reported success of microdosing outside the lab setting and why it has failed to be replicated in controlled research settings. Finally, he shares his opinions on recent developments of drug policy in Australia and the prospects of New Zealand adopting a similar policy.
Australia Law on MDMA and Psilocybin
Get every episode summarized
Each time The Drug Science Podcast publishes, we email you a written briefing from the transcript — the topics, who appeared, and any specific claims, with the ad reads skipped.
Email me new episodesFree for 3 shows. No card needed.
Hosts & guests
No transcript yet
This episode has not been transcribed. Request it and it moves to the front of the queue.
More episodes
More from The Drug Science Podcast
158. The Story of Pharmacology with Prof Rod Flower
The Drug Science Podcast
157. Psychedelics and Christianity with Wendi Rees
The Drug Science Podcast
156. Training Grandmothers to Treat Depression with Dr Dixon Chibanda
The Drug Science Podcast
155. The History of Schizophrenia with Justin Garson
The Drug Science Podcast